AMPH: Amphastar Pharmaceuticals, Inc.
Performance
AMPH +22.26%
Watchlist
Select an item
Summary
AMPH at a glance
AMPH returned +22.26% over the past year and +7.89% a year over five years. Its worst drop in that year was -42.62%, smaller than 33% of stocks on Redstone, and its Sharpe ratio of 0.59 beats 55% of stocks on Redstone. It pays no dividends.
Current Drawdown
-0.07%
Rolling Volatility
32.04%
Actions
Metrics
Risk Indicators
Alpha25.33%
Beta0.54x
Sharpe0.59
Sortino0.75
Omega1.12
Calmar0.52
Martin1.28
Profile
About AMPH
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $1.2B
- Listed
- Jun 2014
- Employees
- 1,976
- Headquarters
- Rancho Cucamonga, CA
- Website
- amphastar.com
Comparisons